Cardio Med S.R.L.
- Address
- lock Available on a paid plan
Cardio Med S.R.L. - Cardiovascular Research Excellence
Cardio Med S.R.L. is a specialized cardiovascular research center dedicated to advancing the treatment of complex cardiac and vascular conditions. The center focuses on evaluating innovative therapeutic approaches for patients with established cardiovascular disease, heart failure, and cardiomyopathies, contributing to the development of next-generation treatments that aim to reduce major adverse cardiovascular events and improve patient outcomes.
- Heart failure with reduced ejection fraction (HFrEF) and novel pharmacological interventions
- Hypertrophic cardiomyopathy symptom management and functional improvement
- Atherosclerotic cardiovascular disease and lipid-lowering therapies, including lipoprotein(a) reduction
- Prevention of major cardiovascular events including myocardial infarction and stroke
The research center's expertise encompasses comprehensive evaluation of cardiovascular disease prevention strategies, with particular emphasis on lipid metabolism disorders and advanced cardiomyopathy therapeutics. Through participation in multicenter international trials, Cardio Med S.R.L. contributes to the clinical evidence base for emerging treatments targeting LDL cholesterol, lipoprotein(a), and metabolic pathways in heart failure, ultimately working to reduce the burden of major adverse cardiovascular events (MACE) in high-risk populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Abcentra LLC1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cardio Med S.R.L.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a): A Randomized, Placebo-Controlled Study | Amgen Inc. | Phase III | Not Recruiting | May 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 2 | Unknown | 2023-09-04 | 2023-09-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.